Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07668648Recruiting
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms). Primary endpoint: Total Opioid Consumption During the First 24 Postoperative Hours at 24 hours. Started Jun 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07668648.